Integrated Platform Vela Diagnostics offers an integrated molecular diagnostics platform that combines Real-Time PCR and Next-Generation Sequencing with scalable, open-channel instruments. This provides labs flexibility to run infectious disease and oncologic panels in a single workflow, creating opportunities to upsell modular additions, consumables, and enhanced data reporting or analytics capabilities.

APAC Focus Headquartered in Singapore with a global footprint, Vela has a strong regional presence ripe for expansion in APAC and other growth markets. Target hospital networks, regional reference labs, and CROs through local distributors and service centers to build adoption, supported by regional training and implementation support.

Cloud & Data Technology stack includes Google Cloud and SAP, signaling readiness for cloud-based data management, remote monitoring, and enterprise integrations. There is an opportunity to offer advanced analytics dashboards, API integrations with existing LIS/LIMS, and pilot AI-driven reporting to differentiate from competitors.

Flexible Financing With mid-range revenue and relatively modest external funding, customers may prefer financing options that minimize upfront costs. Propose equipment leasing, cost-per-test models, and bundled service packages to improve total cost of ownership and accelerate purchasing decisions.

Service & Scalability Open-channel, scalable systems reduce lab barriers for adoption and expansion from small to large operations. Focus on service excellence, predictive maintenance, training, and scalable support plans to drive uptime, renewals, and opportunities with growing labs and multi-site deployments.